Janux Therapeutics, Inc. (NASDAQ:JANX) Receives $89.90 Consensus Target Price from Brokerages
Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) has earned an average rating of “Buy” from the thirteen ratings firms that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, ten have assigned a buy recommendation and two have given a strong buy recommendation to […]
More Stories
DOJ Inquiry Into Fed Chair: What to Know
By Andrew Moran The Federal Reserve was thrust into the spotlight on Jan. 11, after chair Jerome Powell said the...
Their Bodies Were Irreversibly Damaged, Now These Former Transgender Teens Are Fighting for Justice
By Darlene McCormick Sanchez Young people who used to identify as transgender have filed dozens of lawsuits in the past...
Hegseth Says Proposed $1.5 Trillion Military Budget Is ‘Message to the World’
By Ryan Morgan War Secretary Pete Hegseth on Jan. 12 said President Donald Trump’s call for a $1.5 trillion military...
Treasury Secretary Says US Can Easily Cover Any Tariff Refunds
By Jack Phillips Treasury Secretary Scott Bessent said that his department can easily cover any refunds related to tariffs if...
Conrad Black: How US Action Against the Iranian Regime Could Play Out
By Conrad Black The world is waiting for President Trump to bring the horrible and sanguinary disaster of the last...
Judge Blocks Parts of Trump’s Election Order on Citizenship Proof, Ballot Deadline Rules
By Tom Ozimek A federal judge has blocked key parts of President Donald Trump’s election-related executive order in Washington state...